JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hodge, H. C.
Right arrow Articles by Rowe, V. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hodge, H. C.
Right arrow Articles by Rowe, V. K.
Journal of Pharmacology And Experimental Therapeutics, Vol. 104, Issue 2, 202-210, 1952
Copyright © 1952 by American Society for Pharmacology and Experimental Therapeutics


TOXICOLOGICAL STUDIES OF ORTHOPHENYLPHENOL (DOWICIDE 1)

Harold C. Hodge 1, Elliott A. Maynard 1, Harvey J. Blanchet Jr. 1, Howard C. Spencer 2, and Verald K. Rowe 2

1 Division of Pharmacology and Toxicology, University of Rochester School of Medicine and Dentistry, Rochester, New York
2 The Biochemical Research Department, The Dow Chemical Company, Midland, Michigan

1. Orthophenylphenol has a low acute oral toxicity for male rats; the LD50 with its 19/20 confidence limits was found to be 2.7 (2.4 to 3.1) gm./kgm.

2. Orthophenylphenol, when tested as a 5.0 per cent solution in sesame oil, and as a 0.1 per cent aqueous solution of the sodium salt on 200 human subjects, failed to cause either primary skins irritation or skin sensitization.

3. Male and female rats (25 of each sex per group) that were maintained for two years on diets containing 0 (control), 0.02, and 0.2 per cent o-phenylphenol showed no adverse effects as judged by growth, mortality, gross appearance, hematology, urinary sugar and proteins values, organ weights, tissue content of o-phenylphenol, and histopathological examination of various tissues. A similar group of rats maintained for two years on a diet containing 2 per cent of the material deviated from the control by exhibiting slight retardation of growth, histological kidney changes (marked tubular dilation), and the presence of small amounts of o-phenylphenol its the kidney tissue.

4. Dogs (two per group) that received oral doses of 0 (control), 0.02, 0.2, and 0.5 gm./kgm./day of o-phenylphenol for a period of one year showed no adverse effects as judged by body weights, gross appearance, hematological values, urinary sugar and protein values, organ weights, and histopathological examination of the various tissues.

Submitted on October 22, 1951




This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
C Timchalk, S Selim, G Sangha, and M J Bartels
The pharmacokinetics and metabolism of 14C/13C-labeled ortho-phenylphenol formation following dermal application to human volunteers
Human and Experimental Toxicology, August 1, 1998; 17(8): 411 - 417.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1952 by the American Society for Pharmacology and Experimental Therapeutics.